Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mamoru Harada

Showing results (21-30 of 103) with videos related to

Pageof 11
Sort By:
Cancer Immunology, Immunotherapy : CII|June 18, 2016
Age-associated impairment of antitumor immunity in carcinoma-bearing mice and restoration by oral administration of Lentinula edodes mycelia extractSatoru Ishikawa, Yasunori Matsui, Satoshi Wachi, et al.
The Prostate|September 2, 2003
Prostate-specific antigen-derived epitopes capable of inducing cellular and humoral responses in HLA-A24+ prostate cancer patientsMamoru Harada, Kazuhiko Kobayashi, Satoko Matsueda, et al.
Cancer Immunology, Immunotherapy : CII|November 25, 2003
Identification of new prostate stem cell antigen-derived peptides immunogenic in HLA-A2(+) patients with hormone-refractory prostate cancerSatoko Matsueda, Kazuhiko Kobayashi, Yoichi Nonaka, et al.
Oncology Reports|August 4, 2004
Prostate-related antigen-derived new peptides having the capacity of inducing prostate cancer-reactive CTLs in HLA-A2+ prostate cancer patientsMamoru Harada, Satoko Matsueda, Akihisa Yao, et al.
The Prostate|July 21, 2004
Identification of polycomb group protein enhancer of zeste homolog 2 (EZH2)-derived peptides immunogenic in HLA-A24+ prostate cancer patientsRika Ogata, Satoko Matsueda, Akihisa Yao, et al.
Cancer Science|August 9, 2017
Contrasting effects of cyclophosphamide on anti-CTL-associated protein 4 blockade therapy in two mouse tumor modelsYuichi Iida, Nanae Harashima, Takanobu Motoshima, et al.
Cancer Immunology, Immunotherapy : CII|November 1, 2011
Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cellsNanae Harashima, Tohko Inao, Ryu Imamura, et al.
Cancer Science|January 26, 2011
Oral ingestion of Lentinula edodes mycelia extract inhibits B16 melanoma growth via mitigation of regulatory T cell-mediated immunosuppressionKousuke Tanaka, Satoru Ishikawa, Yasunori Matsui, et al.
Anticancer Research|July 5, 2022
Hydroxychloroquine Promotes Bcl-xL Inhibition-induced Apoptosis in BxPC-3 Human Pancreatic Cancer CellsMohammad Mahbubul Hoque, Yuichi Iida, Hitoshi Kotani, et al.
Cancer Science|May 20, 2020
Supplementation of l-arginine boosts the therapeutic efficacy of anticancer chemoimmunotherapyYusuke Satoh, Hitoshi Kotani, Yuichi Iida, et al.
Pageof 11

Showing results (21-30 of 103) with videos related to

Sort By:
Pageof 11
Cancer Immunology, Immunotherapy : CII|June 18, 2016
Age-associated impairment of antitumor immunity in carcinoma-bearing mice and restoration by oral administration of Lentinula edodes mycelia extractSatoru Ishikawa, Yasunori Matsui, Satoshi Wachi, et al.
The Prostate|September 2, 2003
Prostate-specific antigen-derived epitopes capable of inducing cellular and humoral responses in HLA-A24+ prostate cancer patientsMamoru Harada, Kazuhiko Kobayashi, Satoko Matsueda, et al.
Cancer Immunology, Immunotherapy : CII|November 25, 2003
Identification of new prostate stem cell antigen-derived peptides immunogenic in HLA-A2(+) patients with hormone-refractory prostate cancerSatoko Matsueda, Kazuhiko Kobayashi, Yoichi Nonaka, et al.
Oncology Reports|August 4, 2004
Prostate-related antigen-derived new peptides having the capacity of inducing prostate cancer-reactive CTLs in HLA-A2+ prostate cancer patientsMamoru Harada, Satoko Matsueda, Akihisa Yao, et al.
The Prostate|July 21, 2004
Identification of polycomb group protein enhancer of zeste homolog 2 (EZH2)-derived peptides immunogenic in HLA-A24+ prostate cancer patientsRika Ogata, Satoko Matsueda, Akihisa Yao, et al.
Cancer Science|August 9, 2017
Contrasting effects of cyclophosphamide on anti-CTL-associated protein 4 blockade therapy in two mouse tumor modelsYuichi Iida, Nanae Harashima, Takanobu Motoshima, et al.
Cancer Immunology, Immunotherapy : CII|November 1, 2011
Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cellsNanae Harashima, Tohko Inao, Ryu Imamura, et al.
Cancer Science|January 26, 2011
Oral ingestion of Lentinula edodes mycelia extract inhibits B16 melanoma growth via mitigation of regulatory T cell-mediated immunosuppressionKousuke Tanaka, Satoru Ishikawa, Yasunori Matsui, et al.
Anticancer Research|July 5, 2022
Hydroxychloroquine Promotes Bcl-xL Inhibition-induced Apoptosis in BxPC-3 Human Pancreatic Cancer CellsMohammad Mahbubul Hoque, Yuichi Iida, Hitoshi Kotani, et al.
Cancer Science|May 20, 2020
Supplementation of l-arginine boosts the therapeutic efficacy of anticancer chemoimmunotherapyYusuke Satoh, Hitoshi Kotani, Yuichi Iida, et al.
Pageof 11